Evaluation of Medicago sativa L. sprouts as antihyperlipidemic and antihyperglycemic agent

Pakistan Journal of Pharmaceutical Sciences

Volumn 28, Issue 6, 2015, Pages 2061-2074

  Seida, Ahmed ^a,b   El Hefnawy, Hala ^a   Abou Hussein, Dina ^a,c   Mokhtar, Fatma Alzahraa ^a   Abdel Naim, Ashraf ^c,d  

^a CAIRO UNIVERSITY   (Egypt)

^b 6 October Governorate   (Egypt)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d African Union Organization St Abbassia   (Egypt)

Author keywords

Antihyperglycemic; Antihyperlipidemic; Flavonoids; Medicago sativa L. sprouts; Sterols; Streptozotocin

Indexed keywords

10 HYDROXYCOUMESTROL; 4 HYDROXYBENZOIC ACID; 7,4' DIHYDROXYFLAVONE; ACETIC ACID ETHYL ESTER; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; APIGENIN; BUTANOL; CHLOROFORM; CHOLESTEROL; GENISTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOQUERCITRIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDICAGO SATIVA EXTRACT; METFORMIN; METHANOL; PETROLEUM ETHER; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; ROSUVASTATIN; SISSOTRIN; SITOSTEROL; STIGMASTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID; SOLVENT;

ALFALFA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPIDEMIC ACTIVITY; ARTICLE; CELL DEATH; CELL HYPERPLASIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; EPITHELIUM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIVER; LIVER NECROSIS; LYMPHOCYTE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; PANCREAS CELL; PANCREAS DUCT; PANCREAS HEMORRHAGE; RAT; SOLVENT EXTRACTION; SPLEEN; SPROUT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HYPERLIPIDEMIAS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; PATHOLOGY; PHYTOTHERAPY; SHOOT; TIME; WISTAR RAT;

ANIMALS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPIDS; LIVER; MALE; MEDICAGO SATIVA; METHANOL; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT SHOOTS; PLANTS, MEDICINAL; RATS, WISTAR; SOLVENTS; SPLEEN; TIME FACTORS;

EID: 84947913577     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Adebajo AC, Iwalewa EO, Obuotor EM, Ibikunle GF, Omisore NO, Adewunmi CO, Obaparusi OO, Klaesf M, Adetogun GE, Schmidt TJ and Verspohl EJ (2009). Pharmacological properties of the extract and some isolated compounds of Clausenalansium stem bark: Anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J. Ethnopharmacol., 122: 10-19.
2. Alberti KG and Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Diabetic. Med., 15: 539-553.
3. Ammar NM and El-Okbi S (1988). Effect of four flavonoids on blood glucose of rats. Arch. Pharm. Res., 11(2): 166-168.
4. AOAC (1990). Official Methods of Analysis of the Association of Official Analytical Chemist. Washington, D.C, 15th Ed, pp. 951.
5. Batta A K, Xu G, Honda A, Miyazaki T and Salen G (2006). Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat. J. Metbolism., 55(3): 292-299.
6. Baxi DB, Singh PK, Doshi AA, Arya S, Mukherjee R and Ramachadran AV (2010). Medicago sativa leaf extract supplementation corrects diabetes induced dyslipidemia, oxidative stress and hepatic renal functions and exerts antihyperglycemic action as effective as metformin. Ann. Bio. Res., 1(3): 107-119.
7. Bertoli A, Daniela C, Fabio G and Luisa P (2010). Flavonoids isolated from Medicago littoralis Rhode (Fabaceae); their ecological and chemosystematic significance. J. Caryologia., 63(1): 106-114.
8. Bickoff EM, Spencer RR, Lundin RE and Knuckle BE (1966). 3-Methoxycoumestrol from alfalfa: Isolation and characterization. J. Agric. Food. Chem., 14(3): 444-446.
9. Boulos L (1999). Flora of Egypt. Al Hadara Publishing, Cairo, Egypt, Vol I, pp.249-276.
10. Felix P, Jose LC, Aldo EG and Itziar A (1992). Flavonoids in seed coats of Medicago arborea and M. strasseri (Leguminosae). J. Bas. Microb., 32(4): 241-248.
11. Franke AA, Custer LJ, Cerna CM and Narala KN (1995). Rapid HPLC analysis of dietary phytoestrogens from Legumes and from human urine. Proc. Sec. Exp. Biol. Med., 208: 18-26.
12. Fratamico PM and Bagi LK (2001). Comparison of an immunochromatographic method and the TaqMan® E. coli O157:H7 assay for detection of Escherichia coli O157:H7 in alfalfa sprout spent irrigation water and in sprouts after blanching. J. Ind. Microb. Biotech., 27(2): 129-134.
13. Friedwald J, Levy YR and Friedrickson SD (1972). Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. J. Clin. Chem., 18: 499-502.
14. Goh YK, Jumpsen JA, Ryan EA and Clandinin MT (1997). Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia., 40(1): 45-52.
15. Gray, AM and Flatt PR (1997). Pancreatic and extrapancreatic effects of traditional anti-diabetic plant, Medicago sativa (lucerne). Br. J. Nutr., 78: 325-334.
16. Hong YH, Wang SC, Hsu C, Lin BF, Kuo YH and Huang CJ (2011). Phytoestrogenic compounds in alfalfa sprout (Medicago sativa) beyond coumestrol. J. Agric. Food Chem., 59(1): 131-137.
17. Kameswara R, Giri MM, Kesavalu MM and Apparao CH (1997). Herbal Medicine in The Management by Indigenous Resources. Interprint, New Delhi, India, pp. 375-377.
18. Khaleel EA, Gad ZM, El-Maraghy AS, Hifnawy SM and Abdel-Sattar E (2005). Study of hypocholesterolemic and antiatherosclerotic properties of Medicago sativa L. cultivated in Egypt. J. Food and Drug Anal., 13(3): 212-218.
19. Knuckles BE, Defermery D and Koehler GO (1976). Coumestrol content of fractions obtained during wet processing of alfalfa. J. Agric. Food. Chem., 24: 1177-1180.
20. Lust J (1986). The Herb Book. Bantam Books, London.
21. Mabry TJ, Markham KR and Thomas MB (1996). The systematic Identification of Flavonoids. 2nd Ed., Springer Verlag, New York, pp.41-164.
22. Malinow MR, Mclaughin P, Stafford S, Livingston AL and Kohler GO (1980). Alfalfa saponins and alfalfa seeds. Dietary effects on cholesterol-fed rabbits. Atherosclerosis, 37(3): 433-438.
23. Marcovecchio M, Mohn A and Chiarelli F (2005). Type 2 diabetes mellitus in children and adolescents. J. Endocrinol. Invest, 28: 853-863.
24. Martin ML, Castilhob C, Silveira I and Abrev MJ (2006). Liquid chromatographic validation of a quantitation method for phytoestrogens, biochanin-A, coumestrol, daidzein, formononetin, and genistein in lucerne. J. Liq. Chrom. Rel. Tech., 29(19): 2875-2884.
25. Mazahery LH, Yazdy S, Bagheri AR and Bagheri M (2011). Alfalfa (Medicago sativa) shoot saponins: Identification and bioactivity by the assessment of aphid feeding. Br. J. Nutr., 105(1): 62-70.
26. Michael J and Fowler MD (2007). Diabetes treatment, Part 2: Oral agents for glycemic management. J. Clin. Diabetes, 25(4): 131-134.
27. Monirul I, Al-Amin MD, Mahboob AS, Shakila A, Mohammad MH, Nasim S and Sarwaruddin AM (2012). Isolation of Quercetin-3-O-beta-dglucopyranoside from the leaves of azadirachta indica and antimicrobial and cytotoxic screening of the crude extracts. J. Sci., 60(1): 11-14.
28. Newbya VK, Sablon RM, Syngea RL, Casteele KV and Van Sumere KF (1980). Free and bound phenolic acids of lucerne (Medicago sativa cv. europe). Phytochemistry, 19(4): 651-657.
29. O'Keefe JH and Bell DS (2007). Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am. J. Cardiol., 100(5): 899-904.
30. Robertson DA and Home PD (1993). Problem and pitfalls of sulphonylurea therapy in older patients. J. Drugs Aging., 3(6):510-524.
31. Seguin P, Zheng W and Souleimanov A (2004). Alfalfa phytoestrogen content: Impact of plant maturity and herbage components. J. Agric. Crop Sci., 190(3): 211-217.
32. Sheyla LM, Heberth P, Maria LP, Rinaldo CS, Eduardo L, Deoclécio AC and Marcelo ES (2005). Dietary models for inducing hypercholesterolemia in rats. Braz. Archiv. Bio. Tech., 48(2): 203-209.
33. Shingo H, Tacagishi H and Koushi H (1987). Variation in the content and composition of sterols in alfalfa seedlings treated with compactin (ML-236B) and mevalonic acid. J. P. Cell. Physio., 28(4): 709-714.
34. Slauson BJ and Cooper DO (2002). Pathology the study of disease, in Mechanisms of Disease A Textbook of Comparative General Pathology, Mosby, St. Louis, Mo, USA, pp. 1-15.
35. Srinivasan K, Viswanad, B, Lydia A, Kaul CL and Ramarao P (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol. Res., 52(4): 313-320.
36. Stahl E. (1969). Thin Layer Chromatography. 2nd Ed., Springer Verlag, Berlin, Heidelberg, New York, pp.322.
37. Vogel AL, Tatchell AR, Furnis BS, Hannaford AJ and Smith PW (1996). Vogel's Textbook of Practical Organic Chemistry, 5th Ed. Prentice Hall, UK, pp.87-130.
38. Wallace HY (2004). Plasma LDL cholesterol lowering by plant phytosterols in a hamster model. J. Trends. F. Sci. Tech., 15: 528-531.
39. Wild S, Sireee R, Rog G, King H and Green A (2004). Global prevalence of diabetic: Estimate of the year 2000 and projection for 2030. J. Diabetes Care, 27: 1047-1053.
40. Winer BJ (1971). Statistical principles in experimental design. 2nd Ed. McGraw-Hill, New York, pp.1-907.
41. Wu KK and Huan Y (2008). UNIT 5.47 Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr. Protoc. Pharmacol., 40(5): 47-48.